Company Filing History:
Years Active: 2012-2024
Title: Innovations of Katragadda Suresh Babu in Anti-Cancer Research
Introduction
Katragadda Suresh Babu is a prominent inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of anti-cancer research, holding a total of 3 patents. His work focuses on developing novel compounds that can potentially serve as effective anti-cancer agents.
Latest Patents
One of his latest patents is titled "Nimbolide analogs as anti-cancer agents and preparation thereof." This invention relates to nimbolide analogs that are useful in combating cancer. The patent describes a general formula for these analogs, where ring M can be any ring selected from substituted or unsubstituted aryl, heteroaryl, cycloalkyl, and heterocyclic groups. The components A and B can be selected from a variety of elements including carbon, oxygen, nitrogen, sulfur, and hydrogen. Additionally, the R groups can include a range of substituents such as C1-C6 alkyl, aryl, heteroaryl, and various functional groups, allowing for extensive customization of the compounds.
Career Highlights
Katragadda Suresh Babu is affiliated with the Council of Scientific & Industrial Research, where he conducts his research. His work has been instrumental in advancing the understanding of nimbolide analogs and their potential applications in cancer treatment.
Collaborations
He has collaborated with notable colleagues such as Srivari Chandrasekhar and Prathama Satyendra Mainkar, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Katragadda Suresh Babu's contributions to anti-cancer research through his innovative patents highlight the importance of scientific inquiry in developing new therapeutic agents. His work continues to inspire advancements in the field of oncology.